Atlanta, GANCT07217171Now EnrollingIRB Ready

Bladder Cancer Clinical Trial in Atlanta, GA

Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.

Sponsored by EvolveImmune United, Inc

Quick Self-Assessment

See if you qualify for this Atlanta location

Preparing your pre-screening questions…

Expert Care in Atlanta

Access bladder cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related bladder cancer treatment provided free

Apply for This Atlanta Location

Check if you qualify for this bladder cancer clinical trial in Atlanta, GA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Atlanta

    Convenient for GA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Atlanta site if eligible
  4. 4Begin participation

About This Bladder Cancer Study in Atlanta

The goal of this study is to evaluate the safety and effectiveness of EVOLVE104 in participants with advanced urothelial and squamous cell carcinomas who have previously taken standard treatment options, have declined or have been ineligible for treatment with these medications. Participants with advanced or metastatic cancer who meet all eligibility criteria may be eligible to participate in the study.

Sponsor: EvolveImmune United, Inc

Who Can Participate

Inclusion Criteria

Participants must have locally advanced or metastatic cancer with one of the following tumor types: bladder cancer, squamous cell carcinoma of the lung, esophagus, skin, or an anogenital squamous cell carcinoma.
Participant must have documented disease progression during or post treatment with standard of care, dependent upon tumor type.
The cancer must be measurable by CT scan or MRI.
Eastern Cooperative Oncology Group (ECOG) performance status score ≤1.
Anticipated life expectancy of at least 3 months.
Adequate organ function, as indicated by standard blood tests.
Able to provide a fresh or archival tumor biopsy.
Male and female participants must agree to use contraception during the study and for 120 days after the last dose of study drug, except for women who are post-menopausal or surgically sterile. Key

Exclusion Criteria

The participant is a candidate for treatment with a targeted agent known to provide a benefit.
Persistent significant toxicities from prior anticancer therapy.
Brain metastases unless previously treated and stable.
Prior severe or life-threatening immunologic reactions to previous therapies.
Significant medical conditions, including but not limited to:
History of clinically significant cardiac disease
Severe esophageal disease such as esophageal rupture or severe erosive esophagitis.
Active inflammatory corneal or conjunctival inflammation, erosion, or ulcerations.
History of cirrhosis or significant portal hypertension.
Uncontrolled or significant infection.
History of certain other cancers in the past 3 years.
History of arterial thrombosis, stroke and transient ischemic attack within 6 months.
Active or uncontrolled HIV, HBV or HCV infection.
Autoimmune or other condition requiring chronic systemic immunosuppression.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Atlanta?

Yes, this clinical trial (NCT07217171) has an active research site in Atlanta, GA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Bladder Cancer Treatment Options in Atlanta, GA

If you're searching for bladder cancer treatment options in Atlanta, GA, this clinical trial (NCT07217171) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all bladder cancer clinical trials near you to find additional studies recruiting in your area.

More Bladder Cancer Trials in Atlanta, GA

See all bladder cancer clinical trials recruiting in Atlanta — not just this study.

Browse Bladder Cancer Trials in Atlanta →

Browse More Trials by Condition

Bladder Cancer TrialsGallbladder Cancer TrialsAlzheimers Disease TrialsADHD TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Atlanta?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Atlanta, GA